Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Comprehensive Loss

v3.8.0.1
Consolidated Statements of Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Revenue:    
Licenses $ 7,500,000 $ 0
Milestones 0 3,000,000
Collaboration services 85,000 0
Total revenues 7,585,000 3,000,000
Operating costs and expenses:    
Cost of research and development revenue (156,119) 0
Research and development (4,060,000) (43,737,814)
General and administrative (6,937,643) (6,692,786)
Loss from operations (3,568,762) (47,430,600)
Other income (expense):    
Change in fair value of derviative liability 0 2,125,113
Loss on issuance of hybrid debt instruments 0 (1,690,784)
Loss on conversion of debt 0 (6,394,921)
Other expense (41,096) (85,374)
Interest income 16,544 32
Interest expense (1,818) (729,572)
Total other expense (26,370) (6,775,506)
Net loss (3,595,132) (54,206,106)
Accretion of beneficial conversion feature on convertible preferred stock 0 (4,035,260)
Net loss applicable to common stockholders (3,595,132) (58,241,366)
Total comprehensive loss $ (3,595,132) $ (54,206,106)
Basic and diluted loss per share applicable to common stockholders $ (0.41) $ (7.84)
Weighted-average shares of common stock outstanding basic and diluted 8,665,763 7,430,574